Article

Building More Resilient API Supply Chains

Source: Pfizer CentreOne
iStock-1145150074-map-logistics-supply-chain-track

Safe, secure and reliable supply lines for key medicines is one of pharma's top priorities. However, as recent reports about shortages of active pharmaceutical ingredients (APIs) impacting on the supply of key medicines show, there are lessons to be learned to ensure optimum supply chain security.

As we have discussed in previous blogs, de-risking the supply chain is crucial to mitigate the impact from both foreseeable and unforeseeable events.

From a risk management standpoint, it is important to pursue a dualistic, longer term supply strategy that embraces cost control and supply reliability/diversity to improve the integrity and resilience of international supply chains.

So, where should companies begin to develop a more resilient API supply chain? Here are some more key tips to help de-risk.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.

Subscribe to Bioprocess Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Bioprocess Online